Trials / Completed
CompletedNCT03879408
Naproxen Sodium/Acetaminophen Proof of Concept Dosing Study
Randomized, Double-Blind, Placebo And Active Controlled, Study To Evaluate Two Strengths Of Concomitantly Dosed Naproxen Sodium With Acetaminophen, Compared With Naproxen Sodium and Hydrocodone/Acetaminophen In Postoperative Dental Pain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 290 (actual)
- Sponsor
- Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division · Industry
- Sex
- All
- Age
- 17 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Study assessing efficacy and safety of concomitantly dosed naproxen sodium with acetaminophen, compared with naproxen sodium, hydrocodone/acetaminophen and Placebo in a postoperative dental pain.
Detailed description
This is a randomized, double-blind, placebo- and active-controlled, parallel-group study to evaluate the analgesic efficacy and safety of concomitantly administered naproxen sodium 440 mg with acetaminophen 1000 mg and concomitantly administered naproxen sodium 220 mg with acetaminophen 650 mg, compared with a fixed combination of hydrocodone 10 mg/acetaminophen 650 mg, naproxen sodium 440 mg, and placebo over a twelve-hour period after surgical extraction of four third molars.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 440 mg naproxen sodium with 1000 mg acetaminophen | 440 mg naproxen sodium with 1000 mg acetaminophen administered as a single dose of two naproxen sodium 220 mg tablets and two acetaminophen 500 mg tablets |
| DRUG | 220 mg naproxen sodium with 650 mg acetaminophen | 220 mg naproxen sodium with 650 mg acetaminophen administered as a single dose of one naproxen sodium 220 mg tablet and two acetaminophen 325 mg tablets and one placebo tablet |
| DRUG | 10 mg hydrocodone + 650 mg acetaminophen | 10 mg hydrocodone with 650 mg acetaminophen administered as a single dose of two hydrocodone 5 mg + acetaminophen 325 mg tablets and two placebo tablets |
| DRUG | 440 mg naproxen sodium | 440 mg naproxen sodium administered as a single dose of two naproxen sodium 220 mg tablets and two placebo tablets |
| DRUG | Placebo tablet | Single dose of four placebo tablets |
Timeline
- Start date
- 2019-05-28
- Primary completion
- 2019-11-07
- Completion
- 2019-11-13
- First posted
- 2019-03-18
- Last updated
- 2022-12-05
- Results posted
- 2022-12-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03879408. Inclusion in this directory is not an endorsement.